Stocktoria
PharmaCyte Biotech, Inc. PMCB
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2003-09-11
PharmaCyte Biotech, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | 55.6% | 0.6% | -5.9% | -4.7% | -48.0% |
| Return on equity | 59.1% | 1.2% | -5.9% | -4.7% | -53.2% |
| Current ratio | 7.68 | 6.80 | 116.18 | 121.38 | 3.14 |
Source: SEC EDGAR filings · CIK 0001157075 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.